Amy Wilmes
Nurse Practitioner · Clarinda, IANPI 1417242819
Payments from drug & device makers
Across 152 payments — averaging $15.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$681
- Mylan Specialty L.p.$286
- Novo Nordisk$212
- Amgen$154
- Novartis$102
- Biohaven Pharmaceutical Holding Company Ltd.$88
- plus $789 from 26 others
What the payments were for
- Food & beverage$2,312100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$125
How this compares
$2,312 in reported general payments places this provider in the 90th percentile of 1,346 nurse practitioner providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 37 | $41,137 |
| MounjaroTirzepatide | 23 | $24,174 |
| TrulicityDulaglutide | 21 | $23,916 |
| FarxigaDapagliflozin Propanediol | 33 | $23,516 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,643 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,248 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,517 |
| HumalogInsulin Lispro | 23 | $2,534 |
| Rosuvastatin Calcium | 42 | $1,622 |
| LantusInsulin Glargine,hum.Rec.Anlog | 13 | $1,510 |
| Insulin SyringeSyringe-Needle,insulin,0.5 Ml | 11 | $840 |
| Potassium Chloride | 49 | $813 |
| Metoprolol Succinate | 97 | $637 |
| Escitalopram Oxalate | 30 | $531 |
| Lisinopril | 86 | $429 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $42 | $50,62467 claims |
| Novo NordiskRybelsus | $212 | $41,13737 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $25 | $31,76446 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $28 | $16,16029 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,346 nurse practitioner providers in Iowa.
Other nurse practitioner in Clarinda
- Nicole MorganDes Moines$106K
- Julie CoffeyIowa City$31K
- Mary JohnsonDavenport$30K
- Megan Hart FernandezCedar Rapids$19K
- Carla HuberCedar Rapids$18K
- Beth ChiaWest Des Moines$15K
- Margaret KinneyRed Oak$13K
- Abbey ModlinDes Moines$12K
- Jonathon HenningsWaterloo$11K
- Michaela JohnsonWaterloo$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.